Description
Rabbit anti-CD48 Antibody
| Catalog number: | B2014682 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 10 L |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Solution |
| Applications: | molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | BCM1, BCM1 surface antigen, B-lymphocyte activation marker BLAST-1 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- McArdel SL, Brown DR, Sobel RA, Sharpe AH. Anti-CD48 Monoclonal Antibody Attenuates Experimental Autoimmune Encephalomyelitis by Limiting the Number of Pathogenic CD4+ T Cells J Immunol. 2016 Oct 15;197(8):3038-3048.
- Chavin KD, Qin L, Lin J, Woodward J, Baliga P, Kato K, Yagita H, Bromberg JS. Anti-CD48 (murine CD2 ligand) mAbs suppress cell mediated immunity in vivo Int Immunol. 1994 May;6(5):701-9.
- Musgrave BL, Watson CL, Hoskin DW. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity J Interferon Cytokine Res. 2003 Feb;23(2):67-81.
- Yuan D, Guo Y, Thet S. Enhancement of antigen-specific immunoglobulin G responses by anti-CD48 J Innate Immun. 2013;5(2):174-84.
- Tchorsh-Yutsis D, Hecht G, Aronovich A, Shezen E, Klionsky Y, Rosen C, Bitcover R, Eventov-Friedman S, Katchman H, Cohen S, Tal O, Milstein O, Yagita H, Blazar BR, Reisner Y. Pig embryonic pancreatic tissue as a source for transplantation in diabetes: transient treatment with anti-LFA1, anti-CD48, and FTY720 enables long-term graft maintenance in mice with only mild ongoing immunosuppression Diabetes. 2009 Jul;58(7):1585-94.
- Abada-Molina AC, Ji H, Faubion WA, Julien A, Latchman Y, Yagita H, Sharpe A, Bhan AK, Terhorst C. CD48 controls T-cell and antigen-presenting cell functions in experimental colitis Gastroenterology. 2006 Feb;130(2):424-34.
- Hosen N, Ichihara H, Mugitani A, Aoyama Y, Fukuda Y, Kishida S, Matsuoka Y, Nakajima H, Kawakami M, Yamagami T, Fuji S, Tamaki H, Nakao T, Nishida S, Tsuboi A, Iida S, Hino M, Oka Y, Oji Y, Sugiyama H. CD48 as a novel molecular target for antibody therapy in multiple myeloma Br J Haematol. 2012 Jan;156(2):213-24.
- Klyushnenkova EN, Li L, Armitage RJ, Choi YS. CD48 delivers an accessory signal for CD40-mediated activation of human B cells Cell Immunol. 1996 Nov 25;174(1):90-8.
- Flament C, Bellagha K, Rosenthal-Allieri A, Chouaib S, Mami-Chouaib F. CD48 may serve as an accessory molecule for the activation of a subset of human gamma/delta T cells Hum Immunol. 1996 Apr;46(2):82-92.
